Unparalleled Capabilities Spanning the Health Industry, and Beyond
Guidehouse integrates strategy and policy expertise with deep industry partnerships across the healthcare ecosystem – and beyond – helping organizations solve their most complex issues, overcome unique market challenges, and deliver innovative services to their communities and customers.
The Health segment includes public sector and provider administrators, clinicians, scientists, and other experts with decades of strategy, funding, policy, revenue cycle, digital and retail health, managed care, and managed services experience. Visit the Guidehouse Center for Health Insights for their latest insights.
See all Awards & Recognition.
For hospitals, health systems, and physician enterprises, mastering payment, operational, and consumer disruption is key to creating sustainable margins, an engine of growth, and better overall health. Our experts have helped providers nationwide choose the right path for their individual markets, organizations, and the communities they serve.
A rapidly changing healthcare marketplace means that successful organizations must be agile, adaptive, and ready to take on change. Changes may be driven by new models of care, new systems, or a myriad of other innovations. Our public sector health consultants are ready to lead the way.
Guidehouse’s life sciences consulting team collaborates and provides services to pharmaceutical and medical device organizations facing operational, dispute, compliance, and investigative issues.
By providing robust payer strategy, payer-provider partnership, performance improvement, and operational readiness services, Guidehouse supports its payer clients as they challenge the status quo and position themselves for strategic and economic success in growing, securing, and managing the populations they serve.
Guidehouse’s State Government Health team works alongside decision makers in key state and federal agencies to help them transform the delivery and financing of healthcare and other social services, with a particular strength in value-based purchasing. The team brings expert perspectives from the broader Guidehouse Health segment, including extensive experience working with providers and commercial health plans.
Latest From Health
January 26, 2023 Case StudyCyber Threat AssessmentSecurity Audit Identifies and Mitigates Threats
January 26, 2023 InsightsThe Promise of Outcomes-Based Agreements for Cell and Gene TherapiesThere is a pressing need for pharma and biotech manufacturers to find cost-effective ways to help more patients gain access to cell and gene therapies. While many types of innovative payment models exist, outcomes-based agreements are emerging as an attractive best practice option for both manufacturers and payers.
January 25, 2023 InsightsHow Providers Can Use Digital Twins in HealthcareGrowing investments in digital twin technologies are introducing a new generation of intelligence with opportunities to benefit clinicians, healthcare organizations, and patients.
January 13, 2023 InsightsThe Value in Hospital Care at HomeHospital-at-home models can increase capacity, improve patient experiences, and create market differentiation.
January 9, 2023 InsightsImplementing Drug Price Negotiation and Other Inflation Reduction Act ProvisionsThrough the Inflation Reduction Act, the Centers for Medicare & Medicaid Services (CMS) is implementing drug price negotiation to lower prescription drug costs for people with Medicare and reduce drug spending by the federal government.
January 3, 2023 InsightsWant to Know Healthcare Costs in Advance? New Tools Take a Crack at ItAs of Jan. 1, health insurers and employers that offer health plans must provide online calculators for patients to get detailed estimates of what they will owe for a range of services and drugs.
January 3, 2023 InsightsLoneliness is a Public Health Emergency We Can’t Afford to IgnoreToday more than ever, we need a policy that takes the significant physical risk of loneliness into account. We must treat it as the public health issue that it is.